These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17082249)

  • 1. MALDI-TOF mass spectrometry for multiplex genotyping of CYP2B6 single-nucleotide polymorphisms.
    Blievernicht JK; Schaeffeler E; Klein K; Eichelbaum M; Schwab M; Zanger UM
    Clin Chem; 2007 Jan; 53(1):24-33. PubMed ID: 17082249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles.
    Lang T; Klein K; Richter T; Zibat A; Kerb R; Eichelbaum M; Schwab M; Zanger UM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):34-43. PubMed ID: 15190123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz.
    Klein K; Lang T; Saussele T; Barbosa-Sicard E; Schunck WH; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenet Genomics; 2005 Dec; 15(12):861-73. PubMed ID: 16272958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.
    Sukasem C; Cressey TR; Prapaithong P; Tawon Y; Pasomsub E; Srichunrusami C; Jantararoungtong T; Lallement M; Chantratita W
    Br J Clin Pharmacol; 2012 Dec; 74(6):1005-12. PubMed ID: 22471906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.
    Swart M; Skelton M; Ren Y; Smith P; Takuva S; Dandara C
    Pharmacogenet Genomics; 2013 Aug; 23(8):415-27. PubMed ID: 23778320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.
    Wang J; Sönnerborg A; Rane A; Josephson F; Lundgren S; Ståhle L; Ingelman-Sundberg M
    Pharmacogenet Genomics; 2006 Mar; 16(3):191-8. PubMed ID: 16495778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of cytochrome P450 2B6 gene in Han Chinese.
    Guan S; Huang M; Chan E; Chen X; Duan W; Zhou SF
    Eur J Pharm Sci; 2006 Sep; 29(1):14-21. PubMed ID: 16815693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele and genotype frequencies of cytochrome P450 2B6 gene in a Mongolian population.
    Davaalkham J; Hayashida T; Tsuchiya K; Gatanaga H; Nyamkhuu D; Oka S
    Drug Metab Dispos; 2009 Oct; 37(10):1991-3. PubMed ID: 19581387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.
    Desta Z; Saussele T; Ward B; Blievernicht J; Li L; Klein K; Flockhart DA; Zanger UM
    Pharmacogenomics; 2007 Jun; 8(6):547-58. PubMed ID: 17559344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Q172H replacement overcomes effects on the metabolism of cyclophosphamide and efavirenz caused by CYP2B6 variant with Arg262.
    Ariyoshi N; Ohara M; Kaneko M; Afuso S; Kumamoto T; Nakamura H; Ishii I; Ishikawa T; Kitada M
    Drug Metab Dispos; 2011 Nov; 39(11):2045-8. PubMed ID: 21821736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.
    Kwara A; Lartey M; Sagoe KW; Rzek NL; Court MH
    Br J Clin Pharmacol; 2009 Apr; 67(4):427-36. PubMed ID: 19371316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility.
    Yuan ZH; Liu Q; Zhang Y; Liu HX; Zhao J; Zhu P
    Ann Hematol; 2011 Mar; 90(3):293-9. PubMed ID: 20878158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
    Manosuthi W; Sukasem C; Lueangniyomkul A; Mankatitham W; Thongyen S; Nilkamhang S; Manosuthi S; Sungkanuparph S
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1019-24. PubMed ID: 23254426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6.
    Kirchheiner J; Klein C; Meineke I; Sasse J; Zanger UM; Mürdter TE; Roots I; Brockmöller J
    Pharmacogenetics; 2003 Oct; 13(10):619-26. PubMed ID: 14515060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrosequencing-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance.
    Rohrbacher M; Kirchhof A; Geisslinger G; Lötsch J
    Pharmacogenomics; 2006 Oct; 7(7):995-1002. PubMed ID: 17054410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele and genotype frequencies of CYP2B6 and CYP2C19 polymorphisms in Egyptian agricultural workers.
    Ellison CA; Abou El-Ella SS; Tawfik M; Lein PJ; Olson JR
    J Toxicol Environ Health A; 2012; 75(4):232-41. PubMed ID: 22352331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CYP2B6 sequence variants by use of multiplex PCR with allele-specific genotyping.
    Jacob RM; Johnstone EC; Neville MJ; Walton RT
    Clin Chem; 2004 Aug; 50(8):1372-7. PubMed ID: 15178651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese.
    Guan S; Huang M; Li X; Chen X; Chan E; Zhou SF
    Pharm Res; 2006 Sep; 23(9):1983-90. PubMed ID: 16951995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2B6 G516T genotyping in a UK cohort of HIV-positive patients: polymorphism frequency and influence on efavirenz discontinuation.
    Powers V; Ward J; Gompels M
    HIV Med; 2009 Sep; 10(8):520-3. PubMed ID: 19486190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.
    Hesse LM; He P; Krishnaswamy S; Hao Q; Hogan K; von Moltke LL; Greenblatt DJ; Court MH
    Pharmacogenetics; 2004 Apr; 14(4):225-38. PubMed ID: 15083067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.